FLARETX
Live / Applied — Fourth extension granted (statement of use) (as of 29 Jan 2026)
What this means for you
Not registered yet, but its 09 Jun 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90763271
- Mark type
- Stylized text
- Filed
- 09 Jun 2021
- Published for opposition
- 11 Oct 2022
- Attorney of record
- Shane Rumbaugh
Goods and services
- Class 005 — Pharmaceuticals: House mark for chemical and biochemical preparations and substances for medical purposes for treatment and/or diagnosis of cancer, autoimmune diseases and immunological disorders; House mark for pharmaceutical preparations for targeting transcription factors; House mark for immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and immunological disorders; House mark for biological preparations for the treatment of cancer, autoimmune diseases, and immunological disorders
- Class 040 — Treatment of materials: Custom manufacture of biochemical systems, namely, custom manufacture of systems for targeting transcription factors; custom manufacturing for others, namely, manufacturing of pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and immunological disorders
- Class 042 — Scientific and technological services: Bio-technology and scientific services, namely, research, and development services relating to bio-technology and science, namely, transcription factors; pharmaceutical research and development; biological and bio-technology analysis services; scientific and medical laboratory services; biochemistry research services, namely, treating therapeutic targets through biochemical preparations
- Class 044 — Medical, beauty and agricultural services: Providing a website featuring information about the treatment and/or diagnosis of cancer, autoimmune diseases and immunological disorders
Owner
- Flare Therapeutics Inc., Cambridge, MA, US
- Flare Therapeutics Inc., Cambridge, MA, US
Prosecution history
- 30 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Jan 2026 — SOU EXTENSION 4 GRANTED
- 29 Jan 2026 — SOU EXTENSION 4 FILED
- 29 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 05 Aug 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Aug 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 05 Aug 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 26 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Jul 2025 — SOU EXTENSION 3 GRANTED
- 25 Jul 2025 — SOU EXTENSION 3 FILED
- 25 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 05 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Feb 2025 — SOU EXTENSION 2 GRANTED
- 04 Feb 2025 — SOU EXTENSION 2 FILED
- 04 Feb 2025 — SOU TEAS EXTENSION RECEIVED